Background: An increasing number of abdominal aortic aneurysms with unfavorable proximal neck anatomy are treated with standard endograft devices. Skepticism exists with regard to the safety and efficacy of this practice. Methods: A systematic review of the literature was undertaken to identify all studies comparing the outcomes of endovascular aneurysm repair (EVAR) in patients with hostile and friendly infrarenal neck anatomy. Hostile neck conditions were defined as conditions that were not consistent with the instructions for use of the endograft devices employed in the selected studies. Outcome data were pooled, and combined overall effect sizes were calculated using fixed or random effects models. Results: Seven observational studies reporting on 1559 patients (hostile anatomy group, 714 patients; friendly anatomy group, 845 patients) were included. Patients with hostile anatomy required an increased number of adjunctive procedures to achieve proximal seal compared with patients with friendly anatomy (odds ratio [OR], 3.050; 95% confidence interval [CI], 1.884-4.938). Although patients with unfavorable neck anatomy had an increased risk of developing 30-day morbidity (OR, 2.278; 95% CI, 1.025-5.063), no significant differences in the incidence of type I endoleak and reintervention rates within 30 days of treatment between the two groups were identified (OR, 2.467 and 1.082; 95% CI, 0.562-10.823 and 0.096-12.186). Patients with hostile anatomy had a fourfold increased risk of developing type I endoleak (OR, 4.563; 95% CI,) and a ninefold increased risk of aneurysm-related mortality within 1 year of treatment (OR, 9.378; 95% CI, 1.595-55.137). Conclusions: Insufficient high-level evidence for or against performing standard EVAR in patients with hostile neck anatomy exists. Our analysis suggests EVAR should be cautiously used in patients with anatomic neck constraints. (J Vasc Surg
Endovascular aneurysm repair (EVAR) has been a revolutionary development in the treatment of abdominal aortic aneurysms (AAAs). The advent of endovascular technology and the increasing experience and expertise of endovascular specialists have had a profound impact on the management of aortic aneurysms and resulted in improved perioperative outcomes and late results comparable with conventional open surgical repair. [1] [2] [3] The minimally invasive nature of the procedure, which is associated with less physiologic insult and operative trauma, has broadened the applications of aneurysm treatment in patients with high surgical and anesthetic risks who were previously considered poor surgical candidates for conventional treatment. 4 However, unfavorable morphology of the aneurysm and adverse anatomic characteristics of the infrarenal aortic neck in particular have restricted the widespread applicability of EVAR and constitute the "Achilles' heel" of the procedure. 5, 6 Specific anatomic requirements of the proximal aneurysm neck, such as the length and infrarenal angulation, have been defined by aortic endograft manufacturers as prerequisites to ensure satisfactory long-term results.
Approximately 20% of patients with AAAs have aneurysm neck morphology that is inadequate for a standard stent graft. 7 Complex endovascular procedures, such as procedures using custom-made fenestrated endograft systems and the chimney graft technique, have been invented to circumvent anatomic limitations. 8, 9 However, such procedures are technically demanding, require specific endovascular interventional skills, and are performed in special tertiary vascular centers; additionally, morphologic parameters preclude many patients from endovascular treatment with these techniques. Numerous reports describe difficulties performing conventional EVAR in patients with aneurysms with hostile neck anatomy [10] [11] [12] ; conversely, an increasing number of authors have reported successful treatment with standard endografts used in anatomic conditions that are outside specific instructions for use, asserting the effective applicability of EVAR in adverse morphologies. 13, 14 The evolution of evidence-based medicine entails management decisions are based on well-constructed studies and meta-analyses. The objective of the present study was to collect and analyze all available comparative evidence on the outcomes of EVAR in patients with hostile and friendly neck anatomy and undertake a systematic review and critical overview of the literature.
METHODS
Eligibility criteria. The objectives, the methodology of the systematic review and analysis, and the inclusion criteria for study enrollment were prespecified and documented in a protocol. Studies comparing the outcomes of EVAR in patients with hostile and favorable infrarenal neck anatomy were considered eligible. Generally, unfavorable neck conditions were defined as conditions that were not consistent with the instructions for use of the endograft devices used in the selected studies. For a study to be included in the analysis, it should clearly state that the hostile group had morphologic infrarenal neck characteristics that were not within the instructions for use for the specific device (or devices) used. If no such statement was present, potential studies should use the following anatomic features for the definition of the hostile group for them to be considered: neck length <15 mm (distance between the most caudal renal artery and the origin of the aneurysmal dilation of the aorta) and neck angulation >60 degrees (angle of intersection between lines of the long axis of the aneurysm and the long axis of the infrarenal neck). Other anatomic factors, which may or may not have been considered as hostile conditions by the selected studies, included proximal neck thrombus or calcification covering >50% of the circumference of the aortic diameter and a reverse taper morphology (gradual dilation of infrarenal aorta creating a reverse conical appearance). Patients were considered to have a hostile anatomy if one or more of the aforementioned criteria were present on preoperative computed tomography (CT) angiography scans. Studies evaluating performance of stent grafts that are no longer in use or produced by the manufacturers were not selected for analysis. Standard endovascular techniques for the treatment of AAAs were applied; patients or patient groups treated with fenestrated or branched endograft devices or the chimney graft technique were excluded from the analysis. Eligibility assessment of studies for inclusion in this review was performed independently in an unblinded standardized manner by two reviewers. Disagreements between reviewers were arbitrated by discussion.
Definitions and end points. Outcome was expressed by early (perioperative or within 30 days) and late primary and secondary measures. Early primary outcome parameters comprised technical success, perioperative morbidity and mortality, and incidence of type I endoleak and requirement for reintervention within 30 days of treatment. Late primary outcome measures included aneurysm-related mortality, incidence of type I endoleak, and need for any devicerelated or aneurysm-related reintervention during the follow-up period. Secondary outcome end points were defined as the requirement of adjunctive procedures to achieve proximal seal, fluoroscopy time, length of hospital stay, and incidence of graft migration and conversion to open repair at any time during follow-up. Outcome criteria and definitions were based on recommended reporting standards for EVAR, published by the Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery. 15 Information sources and search methods. An electronic search of the literature was undertaken. The search was applied to MEDLINE (database provider PubMed, from 1966 to May 2012), EMBASE (database provider Ovid, from 1980 to May 2012), and Cochrane Central Register of Controlled Trials (May 2012). Related articles suggested by the PubMed search engine and reviews on this area were searched further for additional relevant articles. A second-level search included a manual screen of the reference lists of selected articles identified through the electronic search. No language constraints existed. Expanded Medical Subject Headings (MeSH) and key word searches for "aortic aneurysm," "endovascular procedures," "stents," and "endoleak" and "hostile anatomy," "hostile aneurysm," and "hostile neck" were combined.
Data collection and analysis. A data extraction sheet was developed and pilot-tested on three randomly selected included articles. Data were independently extracted and verified by two authors. The collected variables were divided in three broad categories: (1) baseline clinical and demographic data, anatomic characteristics, and procedurerelated characteristics; (2) primary early and late outcome data; and (3) secondary outcome data, as outlined previously. The methodologic quality of the included studies was assessed according to previously described methods. The Newcastle-Ottawa Scale (NOS) was applied to evaluate the methodologic quality of the studies. This scale was developed to assess the quality of studies using a "star system" (maximum nine stars), in which a study is judged on three broad perspectives: (1) the selection of the study groups, (2) the comparability of the groups, and (3) the ascertainment of outcome of interest. 16 Quantitative analyses of summary statistics from the included studies were conducted because individual patient data were unavailable. From each study, the outcome measures were organized in a 2 Â 2 table to permit calculation of effect sizes for endovascular aneurysm treatment in patients with hostile neck anatomy compared with such treatment in patients with friendly anatomy with regard to each outcome. Late outcome end points, such as incidence of type I endoleak, were transformed into a dichotomous outcome for a specific time period (eg, 1 year). Data were extracted from the text, life tables, or graphs. Study effects were presented using the odds ratio (OR) in a logarithmic scale and the 95% confidence interval (CI) to describe the possible range that the pooled OR could take; any CI that included 1 (the point of equal effect between the two groups) was considered not to be statistically significant. The OR and 95% CI for combined studies were calculated using the fixed effects model of metaanalysis, unless evidence of between-study heterogeneity existed, in which case the random effects model proposed by DerSimonian and Laird was used. 17 The Cochran Q-test was applied to estimate between-study heterogeneity, and P values <.05 were considered significant for heterogeneity. 18 For each trial, the effect by the inverse of its standard error was plotted. Publication bias was assessed both visually evaluating the symmetry of such funnel plots and formally using the Egger regression intercept. 19 Sensitivity analyses were prespecified. Sensitivity analyses were performed, and the treatment effects were examined according to quality and type of study. The Comprehensive Meta-Analysis software, version 2.0 (Biostat, Englewood, NJ) was used for the analyses.
RESULTS

Literature search results
Eight studies met our inclusion criteria, and after adjusting for duplicate publications, seven papers reporting on 1559 patients (hostile anatomy group, 714 patients; friendly anatomy group, 845 patients) entered our metaanalysis models. [11] [12] [13] [14] [20] [21] [22] [23] We identified 19 reports evaluating the performance of various endograft systems in AAAs with unfavorable infrarenal neck anatomic conditions. Of these, two studies were excluded because no control group was available with which to compare the outcomes of the hostile population. 24, 25 Another two studies were not included because although they used neck morphologic criteria generally regarded as hostile, neck conditions were within the instructions for use for the Endurant (Medtronic Cardiovascular, Santa Rosa, Calif) endograft. 26, 27 In five additional studies, either the neck length or the aneurysm angulation was not used to define the hostile anatomy, and the studies were discarded because they did not fulfill our prespecified eligibility criteria. 5, 6, 10, 28, 29 Another study used mixed infrarenal neck and iliac hostile anatomic features and was not included in the analysis. 30 An early report using an endograft that is no longer in clinical use (Ancure; Guidant, Menlo Park, Calif) was also excluded. 31 Another study reporting on treatment with obsolete stent grafts (Fortron [Cordis, Warren, NJ], Endofit [LeMaitre Vascular, Burlington, Mass], Vanguard [Boston Scientific, Natick, Mass], Lifepath [Edwards Lifesciences, Irvine, Calif]) in the minority of their patients (4/147) was allowed to remain in the analysis because these patients accounted for 0.26% of the total meta-analysis population and were considered to have minimal effect on the overall outcome estimates. 22 The process of report selection through literature review is outlined in a flow diagram shown in 
Study characteristics
All seven studies were either prospective or retrospective observational studies comparing the outcomes of EVAR in patients with adverse and favorable neck anatomies. No randomized trials were identified. The study population ranged from 84 to 565 patients, and the period during which these studies were published was from 2004 to 2011. The Newcastle-Ottawa Scale for assessing the quality of the nonrandomized studies is presented in Table I . High scores ($6 stars) were recorded in one of the seven observational studies included in the analysis. Potential selection biases (poor representativeness of the cases and selection of controls) and poorly documented nonresponse rates (exposure category) were recorded in most studies. The criteria used by the authors to define the hostile group and the types of aortic endograft are presented in Table I . Five different endografts systems were used in most of the patients: AneuRx, Talent, Endurant, Zenith (Cook, Bloomington, Ind), and Excluder (Gore, Flagstaff, Ariz). Baseline demographic and clinical data of the study populations are presented in Table II . The outcomes of the selected study cohorts are depicted in Table III . Most of the patients included in this review underwent a surveillance imaging protocol consisting of CT angiography; AbuRahma et al used CT angiography, color duplex ultrasound scanning, or both for follow-up surveillance. 23 The CT protocol is not consistently reported in the studies.
Synthesis of results and outcome
Adjunctive procedures. Four studies reported the need for adjunctive procedures to achieve proximal seal. 11, 13, 20, 22 Adjunctive procedures were required in 22% of patients with hostile anatomy and in 9% of patients with friendly anatomy (OR, 3.050; 95% CI, 1.884-4.938; P < .001) ( Fig 2) . Evidence of heterogeneity was not identified among the studies (P ¼ .636), whereas a low possibility of publication bias was found (P ¼ .810) (Table IV) .
Technical success. Two studies reported technical success rates. 13, 22 Both of them defined technical success as successful introduction and deployment of the stent grafts in the absence of surgical conversion, type I or III endoleak, or graft limb occlusion. Technical success was achieved in 97% and 100% of the patients with hostile and friendly anatomy (OR, 0.139; 95% CI, 0.015-1.275; P ¼ .081) ( Fig 3) . No significant heterogeneity between the studies was found (P ¼ .682) (Table IV) .
Thirty-day mortality. Data on 30-day mortality were reported by four studies. 11, 13, 21, 22 In the hostile anatomy group, 30-day mortality was 2%, and in the friendly anatomy group, 30-day mortality was likewise 2% (OR, 1.022; 95% CI, 0.419-2.493; P ¼ .962) (Fig 4) . There was no significant heterogeneity among the studies (P ¼ .624), and the publication bias was low (P ¼ .391) (Table IV) .
Thirty-day morbidity. Two studies reported 30-day morbidity data. 11, 13 In the hostile anatomy group, 30day morbidity was 15%, and in the friendly anatomy group, 30-day morbidity was 7% (OR, 2.278; 95% CI, 1.025-5.063; P ¼ .043) ( Fig 5) . No significant heterogeneity between these studies was identified (P ¼ .065) (Table IV) .
Reintervention within 30 days. The need for reintervention within 30 days of treatment was reported by one study. 13 Early reintervention was required in none of the Table IV) . Type I endoleak within 30 days. The incidence of early (within 30 days of treatment) type I endoleak was reported by three studies. 11, 13, 22 These endoleaks were detected on CT angiography 30 days after EVAR in two of the studies 13, 22 ; AbuRahma et al 11 used CT angiography or color duplex ultrasound scan or both to examine for endoleak 30 days after intervention. Early type I endoleak occurred in 2% of patients with hostile neck anatomy and in 1% of patients with friendly anatomy (OR, 2.467; 95% CI, 0.562-10.823; P ¼ .232) (Fig 7) . No significant heterogeneity among these studies was identified (P ¼ .539), and the possibility of publication bias was low (P ¼ .574) (Table IV) .
Type I endoleak at 1 year. Data on the incidence of type I endoleak at 1 year were extracted from two studies. 11, 13 Type I endoleak occurred in 10% and 1% of the hostile and friendly anatomy groups at 1 year (OR, 4.563; 95% CI, 1.430-14.558; P ¼ .010) (Fig 8) . No significant heterogeneity between these studies existed (P ¼ .271) (Table IV) .
Reinterventions at 1 year. Data on device-related reintervention at 1 year were extracted from three studies. 11, 13, 21 The incidence of reintervention at 1 year was 5% and 5% in the hostile and friendly anatomy groups (OR, 0.990; 95% CI, 0.547-1.792; P ¼ .974) (Fig 9) . Heterogeneity among the studies was not significant (P ¼ .508), and the probability of publication bias was low (P ¼ .539) (Table IV) .
Aneurysm-related mortality at 1 year. Data on aneurysm-related mortality at 1 year were extracted from three studies. 11, 13, 21 Aneurysm-related mortality at 1 year occurred in 4% of the patients with hostile anatomy, whereas no deaths occurred in the friendly anatomy group at 1 year (OR, 9.378; 95% CI, 1.595-55.137; P ¼ .013) ( Fig 10) . Heterogeneity among the studies was insignificant (P ¼ .331), and the probability of publication bias was low (P ¼ .251) (Table IV) .
DISCUSSION
Endovascular repair has become the mainstay treatment modality of AAAs. Good outcomes with EVAR necessitate assiduous and accurate planning before intervention, focused on morphologic assessments of the proximal neck characteristics and the aortoiliac anatomy. 32 Previous series have shown that unfavorable anatomy of the proximal aortic neck may be responsible for 60% of patients who are excluded from EVAR. 11 The growing experience in the application of endovascular grafts to individual patients with AAA is reflected in the finding in the literature that an 33 This situation has resulted in several authors expanding the anatomic criteria that have to be fulfilled before endovascular treatment is performed. Contradictory results with regard to the outcomes of EVAR in patients with hostile and friendly neck anatomy exist. Our review of the literature and outcome analysis attempted to interrogate the available evidence so as to provide clinicians with a base for clinical implementation and future research. Insufficient clinical information currently exists to provide solid evidence for or against the safety of EVAR in patients with hostile neck anatomy. No randomized trials investigating the potential association between adverse morphologic neck parameters and the outcome of endovascular treatment with standard devices were found. Most of the existing observational studies have low methodologic quality mainly because of patient or control selection biases and inadequate reporting of nonresponders. In addition, even though the pooled outcome estimates are based on inclusion of seven studies in the meta-analysis with 1559 patients, in seven of nine outcome parameters in the meta-analysis, three or fewer of the included studies reported relevant data and could be analyzed. In none of the meta-analyses were all seven studies included. The meta-analyses were often based on a much smaller number of patients than the total population included in this review. Nevertheless, the studies selected for analysis define the hostile group well, show adequate comparability of the cohorts, and use acceptable methods of ascertainment for cases and controls.
Analysis of the available data revealed comparable immediate or early outcomes in the hostile and friendly anatomy groups, as expressed by technical success, incidence of type I endoleak, and requirement for reintervention within 30 days of treatment. Nevertheless, patients with adverse proximal neck anatomy needed an increased number of adjunctive procedures to achieve proximal seal, which reflects the anatomic complexity and the requirement for advanced technical expertise and increased experience of the interventionalist. Such procedures included aortic cuff insertion in most patients. Although no significant differences in perioperative mortality rates between the two groups were detected, patients with hostile neck anatomy developed perioperative morbidity more frequently compared with patients with favorable anatomic neck characteristics. This finding might be explained by possible differences in the comorbid status of the two groups of patients and is consistent with previous reports showing an association between the clinical status and the anatomic complexity of the infrarenal aorta. 30, 33, 34 Additionally, data from the literature confirm that patients with adverse aneurysm anatomy have higher American Society of Anesthesiologists scores. 30, 35 We presumed that all patients included in the analysis were treated electively. However, most of the authors do not clarify whether they treated symptomatic or asymptomatic patients, and this creates confusion in the interpretation of the results.
Meta-analyses of late outcome data revealed inferior performances of standard endograft devices in patients with hostile neck anatomy. A higher incidence of type I endoleak at 1 year was shown in this group of patients, whereas patients with adverse neck morphology had a ninefold increased risk of developing aneurysm-related mortality within 1 year of endovascular treatment. This finding underlines the importance of prudent patient selection and careful morphometric assessment of the aneurysm neck before an endograft is used outside the specific instructions for use. Although the incidence of type I endoleak at 1 year was greater in the hostile anatomy group, the reintervention rate was not. This indicates that many patients with type I endoleak potentially did not undergo reinterventions to correct the endoleak, which may be reflected in the increased aneurysm-related mortality in this group of patients over the same followup period. However, the follow-up period of the selected studies was relatively short, and no conclusions can be reached on the comparative medium-term or long-term performance of standard EVAR in patients' hostile and friendly neck features.
Aneurysm neck anatomy is an independent determinant of successful positioning of an endograft and subsequent exclusion of the aneurysm sac. Failure to adhere to the particular constraints of the device may compromise the outcomes. In the European Collaborators on Stent- Graft Techniques for Aortic Aneurysm Repair (EURO-STAR) database, the investigators evaluated the influence of infrarenal neck angulation and neck length on clinical outcomes after EVAR. 5, 6 Univariate and multivariate analyses were applied to demonstrate a significantly increased risk of proximal endoleaks at short-term and medium-term follow-up after EVAR in patients with short (<15 mm) proximal neck, whereas severe (>60 degrees) infrarenal aortic neck angulation was found to be associated with higher incidences of proximal neck dilation, proximal type I endoleak, and need for secondary interventions. Different endograft devices were used, making meaningful comparisons and the evaluation of their performances in such adverse anatomic conditions difficult. The results of the EURO-STAR study are consistent with the results of our metaanalysis in terms of the incidence of type I endoleak. In the present analysis, a hostile neck anatomy was found to have significant effects on aneurysm-related mortality within 1 year of treatment, which may be explained by the fact that a group of "hostile" criteria was applied by the selected studies to assess their influence on outcomes, whereas the EUROSTAR study evaluated the effects of single anatomic parameters (neck length or neck angulation).
The present meta-analysis combines data across studies to estimate treatment effects with more precision than is possible in a single study. The main limitation is the lack of randomized studies. The results are based on synthesis of outcomes of observational studies, the methodologic quality of which varied considerably. Few authors would argue that using stent grafts outside the instructions for use might result in increasing complications and secondary interventions. The issues with all currently published studies that analyze favorable vs unfavorable neck morphology are that none of these studies are prospective randomized studies, and the instructions for use are device-specific. The definition of favorable vs unfavorable neck morphology is evolving, which makes it very difficult to analyze devices with different instructions for use collectively. Our analysis is limited by the fact that heterogeneity in the criteria used to define hostile anatomy existed among the selected studies. In addition, the authors used specific criteria for "hostile neck" but did not state how many of the patients had two or more of these qualities. Different endograft devices with different instructions for use were used by the authors in various study periods, which would not permit analysis of homogeneous groups of patients and prespecified anatomic criteria. EVAR technology and techniques have rapidly evolved, and the newer generation of stent grafts is designed to improve some of the failures of earlier generation stent grafts. Most operators used more than one stent graft and under ideal circumstances chose devices that might be best suited for a particular patient anatomy. The seven studies analyzed in this meta-analysis all used different definitions for defining unfavorable aortic neck anatomy and evaluated the outcomes in various endografts, many of which are rarely used (eg, AneuRx, Talent) or have been modified from earlier generation devices (eg, Zenith, Excluder). Different devices with special characteristics and properties, used in specific aneurysm anatomies, create heterogeneity among the study populations examined and may have an impact on the overall outcome estimates, which should be considered before interpreting the results of the present analysis.
Constant refinements of aortic endograft designs have contributed to improved results in an ever-increasing number of patients treated with EVAR. Future research with well-designed trials is expected to evaluate further the possibility of applying EVAR in an expanded AAA patient population with adverse proximal neck anatomy treated with new-generation devices. Comparisons of the outcomes of standard EVAR vs fenestrated repair of AAA with hostile neck anatomy may also assist clinicians with the optimal management of these patients.
CONCLUSIONS
Insufficient high-level evidence exists to demonstrate safe use of standard EVAR in patients with hostile neck anatomy. From the present analysis, it may be concluded that EVAR should be used cautiously in patients with unfavorable aneurysm neck anatomy. EVAR should be applied only in patients with high surgical risk in whom all other alternative endovascular treatments, such as fenestrated repair, are not feasible.
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